Cite

    Burchard, J. et al. (2022). Clinical and economic evaluation of a proteomic biomarker preterm birth risk predictor: cost-effectiveness modeling of prenatal interventions applied to predicted higher-risk pregnancies within a large and diverse cohort. Journal of medical economics. pp. 1255-1266. [Online].